Black Diamond
BDTX
Black Diamond (BDTX) news
Recent news
Black Diamond Therapeutics Q2 income from operations USD -12.057 million
AInvest Wire · Aug 5, 2026Black Diamond 2Q EPS C$0.010 vs. C$0.15 Y/Y
AInvest Wire · Jul 30, 2026S&P upgrades Black Diamond CLO 2017-2 DAC Class C to 'BBB-'
Standard & Poor’s Global Ratings has upgraded the credit rating of Black Diamond CLO 2017-2 DAC Class C to 'BBB-', reflecting an improved assessment of the collateral performance and structural characteristics of the collateralized loan obligation (CLO). This action follows a comprehensive review…
AInvest Wire · May 22, 2026Black Diamond Therapeutics GAAP EPS of -$0.36 beats by $0.03
AInvest Wire · Sep 23, 2024Black Diamond Therapeutics announces topline results from phase 1 dose escalation trial of BDTX-1535 for recurrent glioblastoma
AInvest Wire · Dec 13, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.